https://www.pharmalive.com/wp-content/uploads/2020/10/U.S.-strikes-deal-with-Lilly-for-potential-COVID-19-antibody-drug-Reuters-10-28-20.jpeg246370Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-07-14 08:53:562023-07-14 09:23:27Lilly to buy Versanis for up to $1.93 billion to boost obesity drug portfolio